medline.ch Onkologie Urologische Tumoren

	Mitophagy in bladder cancer: a double-edged sword in tumor progression and therapy. J Transl Med Chen Q, Chen T, Gan L, Lu Y, Qian B. PMID: 41963956 [PubMed - as supplied by publisher]
	Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications. Clin Transl Oncol Willisch P, Vázquez-Barreiro B, Plata A, Belmonte IC, Guardia G, Del Castillo-Acuña R, Francolini G, Franzese C, Henríquez JDS, Couñago F, López-Campos F. PMID: 41963635 [PubMed - as supplied by publisher]
	Latin American Consensus for the Diagnosis and Treatment of Metastatic Castration-Sensitive Prostate Cancer. Clin Genitourin Cancer Losco F, Villareal Trujillo N, Jardim DL, Rodríguez-Covarrubias F, Perichón S, Bourlon MT, Martins da Trindade K, Villoldo G, Neciosup S, Sánchez H, Dominguez J, Ibatá L, Martínez-Rojas S, Kopp RM. PMID: 41963237 [PubMed - as supplied by publisher]
	Correlation between histologic features and Decipher genomic risk in prostate cancer biopsies. Ann Diagn Pathol Takeda K. PMID: 41962405 [PubMed - as supplied by publisher]
	Corrigendum to "Long-term outcomes from a multicentre study of HDR monotherapy with a single fraction of 19 Gy for localized prostate cancer" [Radiother. Oncol. 216 (2026) 111385]. Radiother Oncol Sittiwong W, Lydon A, Wylie J, Ahmed I, Challapalli A, Hoskin P. PMID: 41962333 [PubMed - as supplied by publisher]
	Transformer-Enhanced Joint Information Extraction Framework for Bladder Cancer Medical Dialogue Analysis. IEEE J Biomed Health Inform Song Y, Yang Y, Qin J, Zhang Q. PMID: 41961567 [PubMed - as supplied by publisher]
	Evaluating an AI-driven Triaging Workflow for MRI-based Clinically Significant Prostate Cancer Diagnosis: A Simulation Study. Radiol Imaging Cancer Twilt JJ, Saha A, Bosma JS, Giannarini G, Padhani AR, Yakar D, Elschot M, Veltman J, Fütterer J, Huisman H, de Rooij M, PI-CAI Consortium. PMID: 41960994 [PubMed - indexed for MEDLINE]
	Biomaterial-Driven Integrated Therapy for Renal Cell Carcinoma: Renal Cancer Control and Kidney Injury Repair. Research (Wash D C) Song J, Zhang T, Li M, Liu W, Chen T, Qiang H, Wang L, Wu Z, Gao J. PMID: 41960572 [PubMed]
	Use of Single-Cell Data and scPagwas Analysis to Identify T Cell Subsets and Construct a Prognostic Model for Clear Cell Renal Cell Carcinoma. Hum Mutat Yi X, Jia Z, Wu J, Wang S, Yu Y, Kong Y, He X, Huang Y. PMID: 41960370 [PubMed - indexed for MEDLINE]
	Periodic intrafraction image-guided focal dose-escalated stereotactic body radiotherapy for prostate carcinoma on a standard linear accelerator. Phys Imaging Radiat Oncol Serpa M, Wiehle R, Rothe T, Küchler S, Fechter T, Sachpazidis I, Rizzo C, Adebahr S, Kuhn S, Toncheva P, Baltas D, Zamboglou C, Grosu AL, Spohn SKB. PMID: 41958959 [PubMed]
	Clinical management of cancer after kidney transplantation. Front Immunol Hiramitsu T, Ienaga A, Shimamoto Y, Himeno T, Hasegawa Y, Futamura K, Okada M, Narumi S, Watarai Y. PMID: 41958670 [PubMed - indexed for MEDLINE]
	The prognostic value of the lung immune prognostic index in patients with urological cancers: a systematic review and meta-analysis. Front Immunol Lyu Z, Xiao Y, Wang J, Wu R, Yoo KH, Wei W, Zhang Q, Xie Y, Feng D. PMID: 41958645 [PubMed - indexed for MEDLINE]
	Efficacy of androgen deprivation therapy (ADT) in combination with radiation therapy, compared to ADT alone in patients with high-risk prostate cancer: an updated systematic review and meta-analysis. J Med Life Borhan W, Assinnari A, Bakhsh A, Alnazari M, Rajih E. PMID: 41958510 [PubMed - indexed for MEDLINE]
	Comparative analysis of urinary continence recovery after open and laparoscopic radical prostatectomy: a retrospective cohort study. J Med Life Cherciu AI, Persu MC, Bumbea AC, Cherciu MM, Firoiu MC, Vrabie RT, Bolovan E, Arbunea DM, Brînzan DM, Ionescu AI, Bratu OG. PMID: 41958505 [PubMed - indexed for MEDLINE]
	Evaluating BCG response in primary and metachronous non-muscle invasive bladder cancer following prior upper tract urothelial cancer: A systematic review and meta-analysis. Urol Oncol Tan YG, Fong KY, Abern MR, Lim BJH, Leow JJ, Chong TW, Tay KJ, Chen K, Yuen JS, Chan J, Chan JY, Hussain SA, Teoh JY, Kamat AM. PMID: 41956941 [PubMed - as supplied by publisher]
	Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancer. Urol Oncol Sharifi SHH, Ryan JT, Williams A, Tapia-Stoll N, Bitaraf M, Abdshah A, Soodana-Prakash N, Khandekar A, Swain S, Kryvenko ON, Stoyanova R, Pollack A, Castillo PR, Nahar B, Ritch CR, Kava B, Gonzalgo ML, Parekh DJ, Punnen S. PMID: 41956940 [PubMed - as supplied by publisher]
	Associations Between Quality of Life and Disease Progression in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials. Eur Urol Oncol Morgans AK, Ekberg S, Boegemann M, Paracha N, Gallagher E, Gasparini A, Crowther MJ, Shore N, Wallis CJD. PMID: 41956912 [PubMed - as supplied by publisher]
	Re: Chase Peng Yun Ng, Alexander Light, Sai Kalpitha Eragamreddy, et al. Five-year Outcomes for Men after Negative Magnetic Resonance Imaging (MRI) or Negative Biopsy in the RAPID MRI-directed Prostate Cancer Diagnostic Pathway. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.10.015. Eur Urol Kadam A, Misra A, Prakash G. PMID: 41956860 [PubMed - as supplied by publisher]
	Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study. J Immunother Cancer Perez-Gracia JL, Mellado B, Hansen AR, Alonso-Gordoa T, Gomez-Roca C, Løvendahl Eefsen R, Negrier S, Suárez C, Lee JL, Hussain A, Pedrazzoli P, Moreno V, Rodriguez-Vida A, Sosman JA, Waddell T, Bedke J, Park SH, Sznol M, Spychaj L, Andersson E, Julien-Laferriere A, Cheng WY, Watson C, Silva AP, Heichinger C, Staedler N, Sleiman N, Dejardin D, Boetsch C, Evers S, Vardar T, Ardeshir-Tandon C, Dorado Pérez J, Charo J, Keshelava N, Kraxner A, Teichgräber V, Powles T. PMID: 41956546 [PubMed - indexed for MEDLINE]
	DNA repair RAD 18 rs373572 and OGG1 rs1052133 genes polymorphisms association with histological characterization of renal cell carcinoma. Wiad Lek Altemimi IKA, Ameen BAM, Al-Terehi MN, Hussein LM. PMID: 41955591 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 177395

Seite 1 von 8870

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung